Skip to main content
Clinical Trials/NCT05094531
NCT05094531
Unknown
N/A

Implementation of a Post-traumatic Stress Disorder Primary Prevention Program Within the French Army

Direction Centrale du Service de Santé des Armées1 site in 1 country116 target enrollmentApril 26, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Post Traumatic Stress Disorder
Sponsor
Direction Centrale du Service de Santé des Armées
Enrollment
116
Locations
1
Primary Endpoint
Effectiveness of the prevention program in improving resilience at the end of the propgramm
Last Updated
4 years ago

Overview

Brief Summary

Post-Traumatic Stress Disorder (PTSD) is a mental health condition that's triggered by a terrifying event perceived as a life threatening - either experiencing it or witnessing it. Lifetime prevalence of PTSD in the European population is between 0.7% and 1.9%. According to the "dose-response" model, the individuals most exposed to traumatic events (TEs) are those who are most at risk of developing this disorder. This is why it is not surprising to observe a higher prevalence of this disorder in the military population, ranging from 10% to 18% or even 45%, depending on the studies.

In the 1980s, the practice of evidence-based preventive medicine (EBM-Evidence Based Medicine) was developed. It involves the conscientious, explicit, judicious and reasonable use of modern, best evidence in making decisions about the care of individual patients. EBM integrates clinical experience and patient values with the best available research information. Health condition prevention includes several levels of action: primary, secondary or tertiary, depending on the timing of the intervention in the course of the disease.

The aim of this project is to explore the efficiency of primary prevention actions in strengthening the resilience capacities of at-risk professionals, such as the military, in order to prevent the development of PTSD and to improve it prognosis.

The objectives of this project are (i) to design a primary prevention program for PTSD specific to the military population studied and compatible with the operational constraints of field soldiers, (ii) then, to implement / validate it within the operational staff of the Mountain Infantry Brigade (MIB).

Our approach is based on an integrative reading of the processes in the risk of developing PTSD. This biopsychosocial approach targets both the factors specific to the individual (on the physiological and psychological level) and the contextual and social factors relating to his professional environment.

Three dimensions are addressed: (i) biophysiology (by integrating the study of key biomarkers of the neurobiological response to stress, and by strengthening the flexibility of the autonomic nervous system), (ii) psychology (by facilitating and measuring the development of the flexibility of coping strategies to cope with stress as well as by evaluating the moderating role of the sense mission in the development of PTSD) and (iii) the social (by facilitating community strategies aimed at reducing stigmatization and facilitating the use of care for professionals in difficulty in the institutional context).

Registry
clinicaltrials.gov
Start Date
April 26, 2021
End Date
May 31, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
Direction Centrale du Service de Santé des Armées
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Social security affiliation
  • Combat unit soldier with certificate of military efficiency
  • With at least a 12-months employment contract within the MIB
  • Able to attend all the workshops
  • Not member of the Groupement Commando de Montagne

Exclusion Criteria

  • Participant of the PREPAR Phase 1
  • Under chronic medication (daily treatment for at least a month)
  • Unwilling to participate
  • With a overseas deployment scheduled within the next 12 months
  • Adult persons subject to a legal protection measure

Outcomes

Primary Outcomes

Effectiveness of the prevention program in improving resilience at the end of the propgramm

Time Frame: After the completion of the programm, up to 50 weeks

Composite primary endpoint. Significant improvement of resilience will be achieved if 2 or the following 3 criteria are meet: * 20% increase of the PANAS score (Positive And Negative Affect Schedule) * 20% score improvement of the SCS score (Self-Compassion Scale) * 5% score improvement of DRS-15 (Dispositional Resilience Scale)

Secondary Outcomes

  • Follow-up evaluation of the resilience score(Two and six months after the completion of the prevention program)

Study Sites (1)

Loading locations...

Similar Trials